Directorate Change

RNS Number : 1675J

Byotrol PLC

25 March 2010

 



25 March 2010

Byotrol plc

Directorate change

The Board of Byotrol plc ('Byotrol' or the 'Company'), the leading anti-microbial hygiene company, is pleased to announce the appointment of Dr. Gary Millar as the Company's new Chief Executive Officer.  Dr. Millar will join the Company on 1 April 2010.

Dr. Millar, aged 48, has a PhD in Biochemistry from Glasgow University.  He started his career with ICI plc, where he held several senior managerial positions. 

In 1998 Dr. Millar joined the Foseco division of Burmah Castrol plc as Supply Chain Director and was subsequently appointed Operations Director of Foseco Jersey Ltd., a private equity backed MBO, which floated on the London Stock Exchange in 2005.  Between 2005 - 2007, Dr Millar was Managing Director of Foseco Steel UK Ltd.  In 2007 Dr Millar was appointed Group Services Director of Foseco plc, and was a member of Foseco plc's Executive Committee, where he played a key role in Foseco's merger with Cookson plc. 

In 2008 Dr. Millar founded A K Business Management Limited, a management consultancy providing strategic marketing and operational business solutions to UK SMEs. 

Dr. Millar is a full member of the Chartered Institute of Marketing and is a member of the Institute of Directors.

David McRobbie, Byotrol's current CEO, will remain on the Company board with responsibility for the important US operations, and will re-locate to the USA later this year as CEO of Byotrol Inc.

Commenting on the appointments, Ralph Kugler, Chairman, said:

"The Board of Directors is delighted to welcome Gary Millar as its new Chief Executive Officer.  Gary has had an outstanding career, and combines strong senior management achievement with experience of the Life Sciences sector.  Gary has led both small and large businesses, and has an impressive track record of delivering results."

"The Board is also pleased that David McRobbie has agreed to relocate to the US to lead Byotrol Inc.  Success in the US is a key part of our strategy, and the Board is clear that this can only be achieved with experienced senior leadership.  Mr McRobbie will continue to be a member of the Byotrol plc board."

Details of directorships that Dr. Millar holds, or has held in the previous five years, are given below:

Current directorships:

AK Business Management Ltd

Past directorships:

Foseco plc

Foseco (GB) Limited

Foseco (Jersey) Limited

Foseco (MRL) Limited

Foseco (RUL) Limited

Foseco (UK) Limited

Foseco Holding (Europe) Limited

Foseco Holding B.V.

Foseco Holding International Limited

Foseco Holding Limited

Foseco International Limited

Foseco Limited

Foseco Overseas Limited

Foseco Pension Fund Trustee Limited

Foseco Steel (Holdings) China Limited

Foseco Steel (UK) Limited

Foseco Technology Limited

Foseco Transnational Limited

Minerals Separation Limited

New Foseco (UK) Limited

Tamworth UK Limited

Unicorn Industries Limited

Save for the declarations above there is no further information to be disclosed in respect of the appointment of Dr. Millar under Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

Enquiries:

Byotrol plc                                                                                                0161 277 9518

Ralph Kugler, Non-Executive Chairman

Richard Bell, Finance Director

Charles Stanley Securities                                                                      020 7149 6000

Nominated Adviser

Russell Cook / Carl Holmes

Winningtons                                                                                             020 3043 4162

Tom Cooper / Paul Vann                                                                         0797 122 1972

Notes to Editors:

Byotrol Plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

The Byotrol product can be used as a stand alone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services.  Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

 

END

 

 

BOAEANDSAELEEEF